Society for Translational Oncology

02/18/2026

When cancer screening “works,” it can look deceptively simple: test, result, follow‑up, treatment. In reality, every step is fragile, especially for people facing social and structural barriers.

Our latest article explores how patient navigation holds those steps together, shortens time to diagnosis and treatment, and turns equity from an aspiration into a design feature of cancer systems, not an afterthought.

Read more: https://buff.ly/qE5mdiA

When cancer prevention and screening programs succeed, success often appears effortless. A person gets screened, results are delivered, follow-up happens, and treatment begins when needed. In practice…

02/05/2026

is a powerful reminder of the progress being made in cancer care and the impact it continues to have every day 💙

New projections highlight rising cancer diagnoses, alongside meaningful gains in survival thanks to advances in prevention, early detection, and treatment. At the same time, proposed cuts to NCI funding could influence the future of cancer research and care.

Explore the latest data and insights on what this means for oncology nurses and APPs 🔬📊
https://hubs.li/Q041QCgm0

02/04/2026

Today is World Cancer Day.

Cervical cancer is one of the most preventable cancers, yet it continues to take hundreds of thousands of lives every year.

The science is clear. What matters now is ensuring vaccines, screening, and treatment reach every woman, no matter where she lives.

That’s where implementation — not just innovation — makes the difference.

02/03/2026

Every story matters. But too often, cancer care systems overlook the realities of people’s lives.

This World Cancer Day, United by Unique invites us to reflect on what person-centered cancer care really means, and why equity requires more than good intentions. Our latest STO blog explores what it takes to make care work in the real world. https://buff.ly/FDAuGxZ

Imagine a woman in rural North Carolina who has just received an abnormal cervical screening result. She may need to delay her follow-up, not because she fears the procedure, but because her car won’t…

01/21/2026

Cervical cancer prevention is at a turning point. The tools work. Now the challenge is implementing them in ways that reach more women and ensure follow-up care.

HPV testing with self-collection can expand access and improve equity, especially in low-resource settings. But its impact depends on strong clinical workflows, clear referral pathways, and timely treatment.

Our latest article explores what it takes to make self-sampled HPV testing work at scale. Learn more on - https://buff.ly/KiW4Tum

As efforts to eliminate cervical cancer accelerate, attention is shifting from whether screening tools are effective to how they are implemented in routine care. The field is moving beyond a narrative…

12/05/2025

A new international study highlighted in STAT points to a major breakthrough in cervical cancer prevention: a single dose of the HPV vaccine may provide protection comparable to the traditional two-dose schedule.

This has significant implications for global health. A one-dose strategy could make vaccination more accessible, reduce costs, and help reach individuals in communities where completing multi-dose series is challenging.

Cervical cancer remains one of the most preventable cancers and expanding HPV vaccination is a critical step toward closing the equity gap worldwide.

Read more: https://www.statnews.com/2025/12/04/hpv-vaccine-single-shot-cervical-cancer-prevention/

A single HPV vaccination appears just as effective as two doses at preventing the viral infection that causes cervical cancer, researchers reported in a new study.

10/27/2025

ChatGPT demonstrates efficiency in clinical trial recruitment https://buff.ly/cMlROFK

AI-assisted trial recruitment: promising, but not perfect.

A new study in Machine Learning: Health evaluated how ChatGPT (GPT-3.5 and GPT-4) performs in identifying eligible patients for a head and neck cancer trial.

🔹 GPT-4 outperformed GPT-3.5 (AUC 0.838 vs 0.761) in identifying eligible patients
🔹 Structured prompts + expert guidance improved accuracy
🔹 GPT-4 was slower and costlier (7.9–12.4 min, ~$0.15–$0.27 per screen), but still efficient at scale
🔹 Best use case: AI to narrow candidates → clinician to confirm eligibility

Dr. Michael Dohopolski (UT Southwestern) noted that while LLMs can’t yet interpret nuanced clinical criteria, they can dramatically reduce manual workload in screening electronic health records.

As AI evolves, these tools could become valuable adjuncts for research teams facing limited personnel and time pressures, provided models remain HIPAA-compliant and clinician oversight stays central.

Multiple versions of ChatGPT demonstrated efficacy in identifying eligible patients for clinical trial recruitment, showing potential to complement manual chart reviews, according to a study published in Machine Learning: Health.Improving clinical trial recruitment has been an ongoing challenge in t...

10/27/2025

Explore 10 significant events in the history of breast cancer. Discover more here: https://buff.ly/E4AC4xz

Our understanding of breast cancer has evolved significantly since it was first documented nearly 5,000 years ago. Explore some of the many milestones in the history of breast cancer research and treatment.

06/23/2025

A recent study shows that telehealth interventions tailored for older adults with cancer can significantly improve clinical outcomes including lower treatment toxicity and improved survival.
This reinforces the value of geriatric assessments and personalized care even when delivered virtually.

📖 Read more: https://www.healio.com/news/hematology-oncology/20250612/telehealth-program-significantly-improves-outcomes-for-older-adults-with-cancer

A telehealth-based intervention program helped older adults with metastatic cancer improve their physical function, mood and quality of life compared with standard care, according to results of a randomized trial.The investigation, conducted with patients from Brazil, showed Geriatric Assessment-Gui...

06/05/2025

Symptom-assessment intervention may improve care, reduce costs for older adults with cancer

A study presented at the ASCO 2025 Annual Meeting demonstrates that a proactive symptom assessment intervention, involving weekly check-ins by trained lay health workers, significantly reduces acute care utilization among older adults with cancer. Patients receiving this intervention experienced fewer emergency department visits and hospitalizations, leading to an average cost saving of $12,000 per patient. This approach underscores the value of integrating low-cost, scalable interventions to enhance care quality and reduce expenditures in geriatric oncology.

CHICAGO — A weekly symptom-assessment intervention led by trained lay health workers may help reduce acute care use and improve end-of-life care for older adults with cancer, according to data presented at ASCO Annual Meeting.Such an approach could help these patients avoid frequent and costly...

04/30/2025

“Taking care and offering somebody a clinical trial takes more time, more effort—and that’s not necessarily reflected in clinical productivity.”

At this year’s meeting, the PAACT study shared eye-opening interviews with healthcare professionals about why many Black/African American patients still don’t have access to cancer clinical trials.

From mistrust and implicit bias to time burdens and lack of support—there’s a lot to fix. But PAACT has a roadmap. And PAACT 2.0 is already putting it to the test.

Let’s support inclusive, patient-centered research.

Home to the journal Oncology, Cancer Network provides research and opinion on the screening, early detection, diagnosis, treatment, and prevention of cancers.

02/01/2025

Understanding Motives Behind Participation in Cancer Clinical Trials https://buff.ly/4aJRkHc

Exploring the motivations for participating in cancer clinical trials reveals a complex interplay of factors. Participants often join these studies driven by the hope of accessing cutting-edge treatments or contributing to scientific advancements that may benefit future patients. Understanding these motives can improve recruitment strategies and enhance the overall success of clinical trials.

Recent survey study of 978 cancer patients and their relatives uncovered reasons behind their willingness, or lack thereof, to participate in clinical research.